Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omega Diagnostics (GB:CNSL)
:CNSL
Holding GB:CNSL?
Track your performance easily
CNSL Stock Chart & Stats
Day’s Range― - ―
52-Week Range2.30p - 4.48p
Previous CloseN/A
Volume6.91K
Average Volume (3M)537.59K
Market Cap
£9.52M
Enterprise Value4.36M
Total Cash (Recent Filing)$737.33K
Total Debt (Recent Filing)$275.89K
Price to Earnings (P/E)63.6
Beta0.73
Next Earnings
Jul 22, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding237,950,650
10 Day Avg. Volume731,177
30 Day Avg. Volume537,586
Standard Deviation0.14
R-Squared0.08
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.05
Price to Cash Flow (P/CF)-8.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.23
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Omega Diagnostics News
PremiumCompany Announcements
Cambridge Nutritional Sciences Faces Historical Legal Challenge
PremiumCompany Announcements
Cambridge Nutritional Sciences Resolves Legal Dispute with DHSC
PremiumCompany Announcements
Cambridge Nutritional Sciences Settles Dispute with DHSC
PremiumCompany Announcements
Cantor Fitzgerald Europe Increases Stake in Cambridge Nutritional SciencesPremiumCompany Announcements
Cambridge Nutritional Sciences Sees Change in Voting Rights
PremiumCompany Announcements
Cambridge Nutritional Sciences Sees Shareholder Shift
PremiumCompany Announcements
Omega Diagnostics: Spreadex Adjusts Voting Rights Stake
PremiumCompany Announcements
Cambridge Nutritional Sciences Sees Profitability Rise Amid ExpansionCNSL FAQ
What was Omega Diagnostics’s price range in the past 12 months?
Omega Diagnostics lowest share price was 2.30p and its highest was 4.48p in the past 12 months.
What is Omega Diagnostics’s market cap?
Omega Diagnostics’s market cap is £9.52M.
When is Omega Diagnostics’s upcoming earnings report date?
Omega Diagnostics’s upcoming earnings report date is Jul 22, 2025 which is in 180 days.
How were Omega Diagnostics’s earnings last quarter?
Omega Diagnostics released its earnings results on Nov 21, 2024. The company reported 0p earnings per share for the quarter, the consensus estimate of N/A by 0p.
Is Omega Diagnostics overvalued?
According to Wall Street analysts Omega Diagnostics’s price is currently Overvalued.
Does Omega Diagnostics pay dividends?
Omega Diagnostics does not currently pay dividends.
What is Omega Diagnostics’s EPS estimate?
Omega Diagnostics’s EPS estimate is -0.1.
How many shares outstanding does Omega Diagnostics have?
Omega Diagnostics has 237,950,650 shares outstanding.
What happened to Omega Diagnostics’s price movement after its last earnings report?
Omega Diagnostics reported an EPS of 0p in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of Omega Diagnostics?
Currently, no hedge funds are holding shares in GB:CNSL
---
Company Description
Omega Diagnostics
Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. It has three segments: The Allergy and autoimmune division specialise in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases; The Food intolerance division specialises in the research, development, and production of kits to aid the detection of immune reactions to food; and The Infectious disease division specialises in the research, development, production, and marketing of kits to aid the diagnosis of infectious diseases.
---
Technical Analysis
Abingdon Health PLC
―
Avacta Group plc
―
Genedrive
―
Nuformix Plc
―
Ovoca Gold
―
Synairgen
―
---